Furthermore, functionalization with the targeting ligand cRGD enhanced their therapeutic efficacy, achieving pathological remission in primary tumors and immune‐mediated rejection of rechallenged tumors.[52e] These findings highlight the significant potential of polymeric nanocarriers for co‐delivery applications and demonstrate the synergy between STING agonists and chemotherapy in combination cancer therapy. This evidence concerns the gene STING1 and cancer.